Prevalence of lower urinary tract symptoms related to benign prostatic hyperplasia in a urology outpatient clinic in the state of Maranhão 

Article Sidebar

PDF (Português (Brasil))
Published: Jul 17, 2023
DOI: https://doi.org/10.25061/2527-2675/ReBraM/2023.v26i1.1442

Main Article Content

Matheus Amorim Santos
Universidade Federal do Maranhão
Aloiso Sampaio Souza
Universidade Federal do Maranhão
Guilherme Martins Gomes Fontoura
a:1:{s:5:"pt_BR";s:33:"Universidade Federal do Maranhão";}
Rafaela Cristina Araújo-Gomes
Universidade Federal do Maranhão
Fabrícia Silvana Sarmento dos Santos
Universidade Federal do Maranhão
Brunno Leonardo Araújo Oliveira
Universidade Federal do Maranhão

Abstract

Abstract: Benign prostatic hyperplasia (BPH) is a pathophysiological process responsible for most lower urinary tract symptoms (LUTS). The prevalence of BPH remains difficult to determine, especially due to the non-standardization of criteria in the characterization of this clinical condition. This study aimed to analyze the clinical and epidemiological characteristics of individuals with LUTS associated with BPH at a urology outpatient clinic in the city of Imperatriz-MA. This is a prospective, quantitative, cross-sectional study, which used data from the medical records of 70 patients with a previous diagnosis of BPH in a urology clinic in the city of Imperatriz-MA. There was a higher prevalence of LUTS in patients over 70 years of age, black, with complete elementary school, hypertensive, who had a high mean PSA level and high prostate volume. The identification of this profile is necessary to understand the conditions that may compromise the quality of life of patients with LUTS, suggesting the need for preventive and therapeutic measures that take into account the profile of the population treated at the urology clinic.

Downloads

Download data is not yet available.

Article Details

How to Cite
Amorim Santos, M., Sampaio Souza, A., Martins Gomes Fontoura, G., Cristina Araújo-Gomes, R., Silvana Sarmento dos Santos, F., & Leonardo Araújo Oliveira, B. (2023). Prevalence of lower urinary tract symptoms related to benign prostatic hyperplasia in a urology outpatient clinic in the state of Maranhão . Revista Brasileira Multidisciplinar, 26(1), 3-13. https://doi.org/10.25061/2527-2675/ReBraM/2023.v26i1.1442
Issue
Vol. 26 No. 1 (2023): Janeiro - Abril
Section
Artigos Originais
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 
 
 
 
1437/5000
 
The author (s) authorize the publication of the article in the journal;


• The author (s) warrant that the contribution is original and unpublished and that it is not in the process of being evaluated in other journal (s);


• The journal is not responsible for the opinions, ideas and concepts issued in the texts, as they are the sole responsibility of the author (s);


• Publishers have the right to make textual adjustments and to adapt the article to the rules of publication.

Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.

Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg publish in institutional repository or as book chapter), with acknowledgment of authorship and initial publication in this journal.

Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of the published work (See The Effect of Free Access) at http://opcit.eprints.org/oacitation-biblio.html

References

AVERBECK, M. A.; BLAYA, R.; SEBEN, R. R.; LIMA, N. D., DENARDIN, D., FORNARI, A., RHODEN, E. L. Diagnóstico e tratamento da hiperplasia benigna da próstata. Revista da Amrigs, v. 54, n. 4, p. 471-477, 2010.

BARRY, M. J., FOWLER JR, F. J., O’LEARY, M. P., BRUSKEWITZ, R. C., HOLTGREWE, H. L., MEBUST, W. K., COCKETT, A. T., & ASSOCIATION, M. C. O. T. A. U. The American Urological Association symptom index for benign prostatic hyperplasia. The Journal of urology, v. 148, n. 5, p. 1549-1557, 1992.

CHUGHTAI, B., FORDE, J. C., THOMAS, D. D. M., LAOR, L., HOSSACK, T., WOO, H. H., TE, A. E., & KAPLAN, S. A. Benign prostatic hyperplasia. Nature reviews Disease primers, v. 2, n. 1, p. 1-15, 2016.

CLARO, J. D. A. A experiência bem-sucedida do Centro de Referência da Saúde do Homem no tratamento da hiperplasia benigna da próstata. BIS. Boletim do Instituto de Saúde (Impresso), v. 14, n. 1, p. 119-124, 2012.

CUNNINGHAM, G. R.; KADMON, D. Clinical manifestations and diagnostic evaluation of benign prostatic hyperplasia. UpToDate Inc., Waltham, MA. Last reviewed November, 2017.

EGAN, K. B. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urologic Clinics, v. 43, n. 3, p. 289-297, 2016.

ENGER, S. M., VAN DEN EEDEN, S. K., STERNFELD, B., LOO, R. K., QUESENBERRY, C. P., ROWELL, S., SADLER, M. C., SCHAFFER, D. M., HABEL, L. A., & CAAN, B. J. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health, v. 6, n. 1, p. 1-9, 2006.

FERREIRA, G.; CASTRO, M. S. D.; BRIDI, R. Estudo exploratório da utilização de saw palmetto no tratamento da hiperplasia benigna da próstata por urologistas de Porto Alegre. Revista brasileira de farmacognosia. São Paulo, SP. v. 18, n. 2 (Abr./Jun. 2008), p. 222-225, 2008.

GRATZKE, C., BACHMANN, A., DESCAZEAUD, A., DRAKE, M. J., MADERSBACHER, S., MAMOULAKIS, C., OELKE, M., TIKKINEN, K. A., & GRAVAS, S. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European urology, v. 67, n. 6, p. 1099-1109, 2015.

IBGE. INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Estimativas da População Residente no Brasil e Unidades da Federação com Data de Referência em 1º de julho de 2020, 2020. Disponível em: https://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2020/estimativa_dou_2020.pdf. Acesso em: 10/12/2020.

INZUNZA, N.; ANTONIO, J. Manejo Quirúrgico de la hiperplasia prostática benigna y evaluación de eventos adversos según Clavien. Experiencia en Hospital de Villarrica. Rev. chil. urol, p. 34-40, 2014.

JÚNIOR, N.; ZERATTI FILHO, A.; REIS, B. Urologia fundamental. São Paulo, 2010.

LEE, H. N., KIM, T.-H., LEE, S.-J., CHO, W. Y., & SHIM, B. S. Effects of prostatic inflammation on LUTS and alpha blocker treatment outcomes. International braz j urol, v. 40, n. 3, p. 356-366, 2014.

MADANI, A. H., AFSHARIMOGHADDAM, A., ROUSHANI, A., FARZAN, A., ASADOLLAHZADE, A., & SHAKIBA, M. Evaluation of Tadalafil effect on lower urinary tract symptoms of benign prostatic hyperplasia in patients treated with standard medication. International braz j urol, v. 38, n. 1, p. 33-39, 2012.

MESSINA, R.; MIRONE, V. Benign Prostatic Hyperplasia–An economic assessment of fixed combination therapy based on a literature review. Archivio Italiano di Urologia e Andrologia, v. 87, n. 3, p. 185-189, 2015.

NARDOZZA JÚNIOR, A.; ZERATI FILHO, M.; REIS, R. B. D. Urologia fundamental. São Paulo: Planmark, p. 190-191, 2010.

NUNES, R. V., MANZANO, J., TRUZZI, J. C., NARDI, A., SILVINATO, A., & BERNARDO, W. M. Treatment of benign prostatic hyperplasia. Revista da Associação Médica Brasileira, v. 63, n. 2, p. 95-99, 2017.

PARK, M. B., HYUN, D. S., SONG, J. M., CHUNG, H. C., KWON, S. W., KIM, S. C., RANABHAT, C. L., LEE, T. S., & KOH, S. B. Association between the symptoms of benign prostatic hyperplasia and social disparities: Does social capital promote prostate health? Andrologia, v. 50, n. 10, p. e13125, 2018.

PATEL, D. N., FENG, T., SIMON, R. M., HOWARD, L. E., VIDAL, A. C., MOREIRA, D. M., CASTRO-SANTAMARIA, R., ROEHRBORN, C., ANDRIOLE, G. L., & FREEDLAND, S. J. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study. Prostate cancer and prostatic diseases, v. 21, n. 2, p. 238-244, 2018.

PIMENTA, R. C. Rastreamento de Hiperplasia Prostática Benigna. Ciência ET Praxis, v. 6, n. 12, p. 35-38, 2013.

ROEHRBORN, C. G. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF‐ONE. BJU international, v. 101, p. 17-21, 2008.

SHUM, C. F.; LAU, W.; TEO, C. P. C. Medical therapy for clinical benign prostatic hyperplasia: α1 antagonists, 5α reductase inhibitors and their combination. Asian journal of urology, v. 4, n. 3, p. 185-190, 2017.

SBU. SOCIEDADE BRASILEIRA DE UROLOGIA. Urologia Brasil. São Paulo: PlanMark. Rio de Janeiro, 2013. Disponível em: http://www.sbuserver.org.br/publicacoes/SBU_Livro_Urologia_Brasil_2013.pdf. Acesso em: 15/12/2020.

SOLER, R., ANDERSSON, K.-E., CHANCELLOR, M. B., CHAPPLE, C. R., DE GROAT, W. C., DRAKE, M. J., GRATZKE, C., LEE, R., & CRUZ, F. Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. European urology, v. 64, n. 4, p. 610-621, 2013.

TAOKA, R.; KAKEHI, Y. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia. Asian journal of urology, v. 4, n. 3, p. 158-163, 2017.

TEIXEIRA, T. F. C. Prostatectomia Simples Aberta-Qual é a melhor técnica? Dissertação de Mestrado. Universidade do Porto – U.Porto; 2016.